Quantum Genomics
Develops a new class of medications for resistant hypertension and heart failure.
ALQGC | PA
Overview
Corporate Details
- ISIN(s):
- FR0010783837 (+4 more)
- LEI:
- 969500TFCD8K9RPM9K97
- Country:
- France
- Address:
- 6 RUE CAMBACERES, 75008 PARIS
- Website:
- https://quantum-genomics.com/
- Sector:
- Manufacturing
Description
Quantum Genomics is a biopharmaceutical company focused on developing a new class of medications for cardiovascular diseases with high unmet medical needs, such as difficult-to-treat or resistant hypertension and heart failure. The company's core research is based on a breakthrough therapeutic approach involving the inhibition of Brain Aminopeptidase A (BAPA). Its lead drug candidate, firibastat, is a first-in-class BAPA inhibitor designed to offer a novel treatment mechanism for managing these conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-13 18:00 |
Report de l'Assemblée Générale Mixte du 30/06/2025
|
French | 116.4 KB | ||
| 2025-04-30 20:00 |
Quantum Genomics publishes its 2024 annual financial statements and announces a…
|
English | 206.5 KB | ||
| 2025-04-30 20:00 |
Quantum Genomics publie ses comptes annuels 2024 et annonce un changement de li…
|
French | 254.0 KB | ||
| 2025-04-08 08:00 |
Quantum Genomics fait un point sur sa situation
|
French | 688.8 KB | ||
| 2025-04-08 08:00 |
Quantum Genomics provides an update on its situation
|
English | 626.0 KB | ||
| 2024-10-29 18:00 |
Quantum Genomics publie ses résultats du 1er semestre 2024 et annonce la nomina…
|
French | 241.2 KB | ||
| 2024-09-27 08:00 |
Quantum Genomics sécurise un financement avec le fonds Akkadian Partners Fund e…
|
French | 74.5 KB | ||
| 2024-09-04 18:00 |
Quantum Genomics reviewed its financial situation and announced that it has fil…
|
English | 175.5 KB | ||
| 2024-09-04 18:00 |
Quantum Genomics fait un point sur sa situation financière et annonce qu'elle a…
|
French | 150.0 KB | ||
| 2024-07-03 13:00 |
BILAN SEMESTRIEL S1 DU CONTRAT DE LIQUIDITE CONTRACTE AVEC LA SOCIETE DE BOURSE…
|
French | 275.3 KB | ||
| 2024-03-13 18:00 |
Quantum Genomics publie ses résultats de l'exercice 2023. Le rapprochement avec…
|
French | 193.8 KB | ||
| 2024-03-13 18:00 |
Quantum Genomics publishes its results for the 2023 financial year. The merger …
|
English | 166.3 KB | ||
| 2024-01-10 16:35 |
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | ||
| 2024-01-10 16:30 |
Bilan au 29 décembre 2023 du contrat de liquidité contracté avec la Société de …
|
English | 297.2 KB | ||
| 2023-12-14 18:05 |
Quantum Genomics enters into exclusive negotiations with ExactCure
|
English | 286.1 KB |
Automate Your Workflow. Get a real-time feed of all Quantum Genomics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Quantum Genomics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Quantum Genomics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
